Deep Intelligence Across Industries

Company Headquarters: Wiltshire, England, UK Founded: 1998 Workforce: 210 Company Working: Alliance Pharma PLC is a specialty pharmaceutical company with a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products currently. In 2015, the company acquired MacuVision Europe Limited for an initial consideration of EUR 5.5 million (USD 7.15 million). MacuVision is into selling MacuShield, an eye care treatment designed to be taken by sufferers of dry age-related macular degeneration and other eye conditions. The company distributes its products through wholesalers, retail pharmacies, hospitals and renowned international network of distributors. It has offices in Paris, Milan, Madrid, Düsseldorf, Dublin, Shanghai, and Singapore, in addition to its headquarter in England.

Company Headquarters: Geneva, Switzerland Founded: 1945 Workforce: ~475,000 Company Working: Alcon develops supplements, contact lenses and solutions, eye drops, and other products for surgical and vision care areas, such as cataracts, glaucoma, retinal diseases, and refractive errors. The company has a presence in over 70 countries and serves patients in more than 140 countries. It invests a substantial amount of funds in research and development to meet customers’ needs and patients’ demands. Also, it has active collaborations with various service providers. For instance, the company has a partnership with SightLife, the Eye Donation Counselor program established in hospitals in India, which is enabling cornea transplant surgeries that might not have been possible otherwise. Alcon comprises of a strong pipeline for the future, constituting non-Rx dry eye drops, contact lens care solutions, ocular vitamins, non-Rx allergy drops, and non-Rx red-eye drops in the area of ocular health.

Company Headquarters: Valence, France Founded: 1997 Workforce: ~436 Company Working: Amplitude Surgical (Amplitude) is engaged in developing, manufacturing, and marketing orthopedic products. The company also operates in research and development and sales of prosthetics. Its products include prosthetics and surgical equipment such as i.M.A.G.E, AMPLIVISION, and E.T.O.I.L.E. The company develops high-end prosthetic products covering main disorders affecting the hip, knee and extremities, and notably foot and ankle surgery. Amplitude has a sales presence in more than 35 countries globally. It operates on the lower-limb market through the intermediary of its Novastep subsidiaries in France and the US.

Company Headquarters: Denver, Colorado, US Founded: 1994 Workforce: ~77,000 Company Working: DaVita Inc. (DaVita) consists of two major divisions, the US dialysis & related lab services and ancillary services & strategic initiatives. The US dialysis and related lab services business is a provider of kidney dialysis services in the US for patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company conducts clinical trials for drug and device development customers as well as DaVita’s strategic need to innovate clinical care for patients with ESRD. On June 19, 2019, it completed the sale of the DaVita Medical Group (DMG) business, a patient and physician-focused integrated healthcare delivery and management company, to Collaborative Care Holdings, LLC (Optum), a subsidiary of UnitedHealth Group Inc. It operates or provides administrative services to a total of 259 outpatient dialysis centers, which includes consolidated and nonconsolidated centers located in ten countries outside the US, serving approximately 28,700 patients.

Company Headquarters: Sydney, Australia Founded: 1987 Workforce: ~ 36,000 Company Working: Sonic Healthcare Limited (Sonic) operates in various segments in the healthcare industry, such as radiology, laboratory medicine/pathology, medical centers/primary care, life screen, occupational and general medicine, clinical trials, and food and water testing. Sonic’s clinical trial segment has one of the most dedicated laboratory segments, which provides a wide range of clinical trial support to pharmaceutical and biotechnological industries. The company operates in countries such as Australia, the US, Germany, Belgium, Switzerland, the UK, Ireland, and New Zealand, and has an employee workforce of around 35,000+ employees globally.

Company Headquarters: London, UK Founded: 2015 Workforce: ~22,000 Company Working: SYNLAB Bondco PLC (SYNLAB) was incorporated on 9 June 2015 and acquired the Labco Group on 7 August 2015 and the Synlab Group on 1 October 2015. The main business of the SYNLAB Bondco PLC is the supply of medical diagnostic services, primarily relating to clinical diagnostics testing, and screening services. It is also active in analytics & services business covering notably environmental and food testing. This company focuses on medical supplies, trade, clinical trials, and offers consulting services. Its customers include doctors, patients, clinics, university hospitals, retirement and nursing homes, veterinary practices, business enterprises, communities and authorities, and pharmaceutical companies. SYNLAB particularly focuses on the implementation of innovative laboratory medicine methods and networking specialist diagnostic competences (SYNLAB Centers of Excellence). SYNLAB maintains its strategic business units in individual countries for veterinary medicine and environmental analysis. This service portfolio is rounded off by expert medical imaging centers in certain countries. The group works closely with research institutions and universities and maintains an educational institution named the SYNLAB Academy. The company is present in more than 37 countries globally. It has a workforce of around 22,000 employees spread across the globe. It performs approximately 450 million test results per annum. It benefits from a network of over 475 laboratories across 37 countries worldwide, including the core markets of Germany, France, Switzerland, Italy, and Spain. It completed 33 acquisitions in 2017 and 21 acquisitions in 2018.

Company Headquarters: New Jersey, US Founded: 1981 Workforce: ~350,600 Company Working: BioReference Laboratories, Inc. (BioReference) is one of the largest full service clinical diagnostic laboratories in the US. The company offers testing and related services to long term care facilities, employers, physician offices, clinics, hospitals, governmental units, and correctional institutions. It also provides a wide-ranging test that focuses on molecular diagnostics, anatomical pathology, genetics, and women’s health. BioReference is currently present in nine locations of the US (New York, Massachusetts, California, Texas, and others). It is a wholly-owned subsidiary of OPKO Health, Inc.

Company Headquarters: Quebec, Canada Founded: 2006 Workforce: ~13+ Company Working: Dacima Software Inc. (Dacima) was founded through a partnership between a healthcare team and information technology experts, who had more than 15 years of experience. It was founded in 2003, however, it was incorporated in 2006. The company developed a state-of-the-art clinical software and patient registry database software, that solves the major strategic and operational challenges in business. Dacima is an innovator in the web Electronic Data Capture (EDC) technology. The EDC software includes features and capabilities that can facilitate cleaner data, and more efficient study management and data collection. The Dacima Clinical Suite EDC Study Designs include randomized clinical trials, observational studies, patient registries, web surveys, ePRO/eCOA, eDiaries, telephone interviews, meta-analysis, and administrative databases.

Company Headquarters: North Carolina, US Founded: 1982 Workforce: ~58,000 Company Working: IQVIA, formed through the merger of IMS Health and Quintiles, is a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry. IQVIA applies human data science by leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation, and accelerate improvements in healthcare outcomes. Powered by the IQVIA CORE, the company delivers unique and actionable insights at the intersection of large scale analytics, transformative technology, and extensive domain expertise. The company also delivers execution capabilities to help biotech, medical device, and pharmaceutical companies, medical researchers, government agencies, payers, and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors, and scientific advances, in an effort to advance their path toward cures. The company conducts operations in more than 100 countries, such as India, China, Australia, Africa, Belgium, Germany, and Brazil.